Standard Biotools (LAB) Change in Cash (2010 - 2026)

Standard Biotools (LAB) has 17 years of Change in Cash data on file, last reported at $144.6 million in Q1 2026.

• On a quarterly basis, Change in Cash rose 1042.0% year-over-year to $144.6 million in Q1 2026; TTM through Mar 2026 was $114.4 million, a 184.82% increase from a year earlier, with the FY2025 full-year figure at -$45.5 million, down 139.14% from the prior year.
• Change in Cash for Q1 2026 stood at $144.6 million, up from -$8.7 million in the prior quarter.
• Over the last five years, Change in Cash for LAB reached as high as $235.8 million in Q1 2024 and fell as low as -$62.6 million in Q3 2023.
• Historically, Change in Cash has averaged $14.0 million across 5 years, with a median of -$8.7 million in 2025.
• On a YoY basis, Change in Cash climbed as much as 1997.52% in 2023 and fell as far as 342.37% in 2023.
• Year by year, Change in Cash stood at $21.1 million in 2022, then tumbled by 232.41% to -$28.0 million in 2023, then plunged by 54.27% to -$43.1 million in 2024, then soared by 79.8% to -$8.7 million in 2025, then surged by 1759.79% to $144.6 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $144.6 million in Q1 2026, -$8.7 million in Q4 2025, and -$29.2 million in Q3 2025.